A B S T R A C T Studies of a number of properties of the pathological -vA-proteins in the first four cases of the recently recognized alpha-chain disease demonstrate that, as in -v-heavy-chain disease, the abnormal protein is devoid of light chains and represents a portion of the a-heavy chain related to the Fc-fragment. In two patients, serum electrophoresis showed a broad abnormal band, whereas in the two others the pathological protein was not noticeable on the electrophoretic pattern. The diagnosis of a-chain disease can be established without purification of the protein by immunoelectrophoresis and gel diffusion experiments using selected antisera to 'vA and a reference a-chain disease protein. All four proteins belonged to the al-subclass, displayed electrophoretic heterogeneity. and showed a strong tendency to polymerize. The polymers occurred in vivo and were held together both by disulfide bonds and by strong noncovalent forces. Two of the three purified proteins had a very high carbohydrate content. The abnormal protein was always found in concentrated urines in variable but generally low amounts. It was not detected in parotid saliva but was present in significant amounts in jejunal fluid of all four patients. The a-chain disease protein was shown to be associated with the secretory piece in external secretions of two patients.
INTRODUCTION
When Franklin reported the first case of av-heavy-chain disease, an uncommon form of malignant lymphoma characterized by the presence in serum and urine of a naturally occurring immunoglobulin representing mainly the Fc-fragment of the '-ychain, he anticipated that similar conditions involving a-and A-chains would ultimately be identified (1, 2) . In fact, a new type of immunoglobulin abnormality, characterized by the presence in serum and urine of a protein devoid of light chains and closely related to the heavy polypeptide chains of -yAl-globulin, has recently been described in this laboratory (3) . In view of the similarity with -y-heavychain disease, the designation "alpha chain disease" was applied to the corresponding syndrome.
The first recognized patient was a young Arab female affected with a malignant lymphoma involving the whole length of the small intestine; she exhibited a severe malabsorption syndrome (4) . This type of lymphoma has been noted to be frequent in young Arabs and nonAshkenazi Jews by several Israeli authors (5, 6) . Dur- ing the past several months, we have detected among patients from Paris hospitals with similar clinicopathological features three new cases with an analogous immunoglobulin A abnormality. Thus alpha chain disease probably represents a true entity defined by characteristic clinical, biological, and pathological features. The case histories of these three additional patients will be published in detail elsewhere (7) (8) (9) . This report presents some immunological and physicochemical properties of the pathological immunoglobulin in these four cases of alpha chain disease, as well as some data on cellular synthesis.
METHODS
Collection and preservation of biological fluids. Some blood samples from the two last patients were collected in iodoacetamide at a final concentration of 2 mg/ml to suppress disulfide interchange. 24-hr urine samples were collected in 200 mg iodoacetamide and 1 g sodium azide. They were filtered and concentrated by negative pressure dialysis in VisKing 23/32 tubing in the presence of iodoacetamide. Jepunal fluid was collected in a preservative mixture (an aqueous solution containing 131 mg/ml of e-aminocaproic acid, 10 mg sodium azide, 1 mg kanamycin, 20 mg iodoacetamide, and 10 mg of soybean trypsin inhibitor/ml in a ratio of 9: 1, v/v). Immediately after collection, jejunal fluid was heated at 560C for 30 min. After filtration and centrifugation, it was concentrated by negative pressure dialysis against the preservative mixture diluted 10 times in buffered saline. Parotid saliva was collected with a special plastic cup' and was concentrated by negative pressure dialysis in VisKing 23/32 membranes. All samples were stored frozen at -20'C.
Immunological studies Antisera were prepared in rabbits by immunization with antigens in complete Freund's adjuvant. 20 antisera to several purified yA-myeloma proteins were made specific by suitable absorption with serum of patients having selective -yA deficiency and, if necessary, light chains, -yG, or agammaglobulinemic serum. Several control experiments were performed in order to ascertain that these absorbed antisera reacted only with -yA. They were then tested against several -yA-myeloma proteins of known light-and heavy-chains subclasses in order to select: (a) antisera demonstrating antigenic deficiency of the -yA2-proteins (10) (11) (12) and (b) antisera containing antibodies which precipitate only when K-or X-chains are combined to a-chains. Antisera were also prepared to the purified protein of the first case of alpha chain disease (T. L.), to -yG and -yM, and to several K-and X-Bence Jones proteins. All were made specific by suitable absorption. Antisera to K and X chains were selected which precipitated both with Bence Jones proteins and yA or 'yGmyeloma proteins of the corresponding light-chain type. A monkey antiserum specific for human 'yA2-proteins (13) was kindly provided by Dr. H. G. Kunkel. Antisera to human colostral yA were kindly provided by Doctors T. B. Tomasi and J. P. Vaerman. When absorbed with concentrated normal human serum, one of these antisera reacted only with the "secretory piece," whereas the other reacted also with lactoferrin.
Immunoelectrophoresis was performed with 2% agar gel in barbital buffer, ionic strength = 0.05, pH 8 (14) by use of standard calibration curves. The inhibition of precipitin reactions was detected by a screening test in gel diffusion as previously described (15) .
-y-globulin fractions from the specific antisera were prepared for immunofluorescent studies by standard techniques (16) . Several anti--yA sera including one against T. L. protein and a number of anti-light-chain sera were used, whereas only one anti--yG and anti--yM sera were conjugated. The specificity of the absorbed antisera was carefully tested 'Lashley cups, parotid. Plastic-Craft Products Corp., West-Nyack, N. Y. before conjugation, as stated above. The specificity of the fluorescein-conj ugated globulins was tested on stored bone marrow smears (known to contain numerous plasma or lymphoid cells) from patients with myeloma or macroglobulinemia of well established class and type. Several peroral suction-biopsy jejunal fragments were obtained from the four patients. Rectal biopsy specimens and surgical small intestine biopsies were available from two patients. The specimens were usually quick-frozen and sectioned (4 1A) in a cryostat. The sections were air-dried, fixed for 5 min in absolute methanol, and promptly stained. Some specimens were previously fixed in neutral isotonic buffered formaldehyde (10%) for 4 hr at 4VC, followed by a 30% sucrose solution wash overnight, according to Eidelman and Davis (17) . A few specimens were stored at -80'C for later processing. Bone marrow was studied in all patients. White cells were washed three times in a 5% bovine albumin solution in Hanks' buffer. The smears were fixed in ethanol for 3 min and immediately stained. Mesenteric lymph nodes were available from two patients. One of them was necrotic and not usable. The lymph node cells, obtained by gentle teasing, were washed and processed exactly as bone marrow cells. Sections and smears were incubated with the labeled antisera by standard methods (16) . A rhodamine-conjugated normal rabbit fraction II was used as a counterstain.
In vitro protein synthesis by the same tissues was studied by the technique of Hochwald, Thorbecke, and Asof sky (18) . The specimens of small intestine, rectum, and mesenteric node biopsies, as well as the bone marrow cells, were submitted to short-term (24-36 hr) culture in the presence of "C-labeled amino acids (1 ,uc/ml of a mixture of L-valine-`C, L-leucine-"C, and L-phenylalanine-QC). The concentrated cell extracts were analyzed by immunoelectrophoresis and subsequent radioautography. Normal serum and the patient's serum were usually used as carriers; some experiments were performed without any carrier.
Isolation of the pathological protein and physicochemical studies Preparative procedures. Preparative zone electrophoresis was performed in Pevikon C 870 2 under an electric potential of 7 v/cm-' for 48 hr at + 4VC, using barbital acetate buffer, pH 8.6, and ionic strength 0.05 with 20% v/v glycerol to insure good quality of imprints for protein-staining as previously described (19) .
Gel filtration chromatography was performed on a 100 cm X 3.5 cm I.D. column, packed with Sephadex G200 equilibrated with 0.1 M Tris-HCI buffer, pH 8.0, 1 mole/liter in NaCi, and 1% in N-butanol. To eliminate traces of anthrone-positive material, the Sephadex had been repeatedly boiled and washed in distilled water. The ratio of the applied sample volume to the total Sephadex bed volume was kept near 1: 100.
In view of the considerable electrophoretic heterogeneity and tendency towards polymerization of the alpha chain disease proteins, a three step schedule was adopted for its purification: (a) the broad electrophoretic band containing the "alpha chain protein" (a-CP) was eluted after preparative electrophoresis in Pevikon blocks; (b) after removing the low density lipoproteins by ultracentrifugation, this block fraction was submitted to Sephadex G200 gel filtration. The first major and asymmetrical peak eluting between Ve/Vo 1 and 1.4 contained mainly the a-CP polymers together with a2M and small amounts of yM; (c) the 1st two-thirds of aFosfatbolaget, Stockholm, Sweden. this peak were collected and fractionated again by Pevikon block electrophoresis. The segments (1 cm wide) were eluted, concentrated, and tested for a2M and yM contaminants. Some of these fractions were found to contain only the a-CP when tested in gel diffusion at a concentration of 20 mg/ml. The final yield of purified material was less than 5% of the starting material.
Mild reduction of the polymeric forms of the a-CP was performed at room temperature either with 0.3 M 2-mercaptoethanol for 1 hr in 0.5 M Tris-HCl buffer, pH 8.0, or with 0.01 M dithiothreitol for 30 min in 0.2 M Tris-HCl buffer, pH 8.6. This was followed by alkylation with a 10% equivalent excess of iodoacetamide for an equal period of time at 0°C. The reduced and alkylated proteins were dialyzed in acetylated 23/32 Visking bags against distilled water for 4 hr and then again against the desired solvent overnight in the cold (except for some experiments in 6 M guanidine HCl, 1 mole/liter in acetic acid where the dialysis time was 48 hr at room temperature). In some experiments, a-CP were extensively reduced by 0.05 M dithiothreitol in 8 M urea rendered 0.5 mole/liter in Tris-HCl buffer, pH 9.0. The reduction was stopped after 1 hr at room temperature with a 10%o equivalent excess of iodoacetamide for 30 min. After dialysis for 24 hr against several changes of 1 M acetic acid, the material was lyophilized.
Human -yA-myeloma proteins were isolated by block electrophoresis followed by G200 Sephadex gel filtration in phosphate-buffered saline, pH 7.2. In some instances, the yA was further purified by chromatography on carboxymethylcellulose, using a gradient of acetate buffer at pH 5.0 from 0.29 to 0.074 mole/liter. Light and heavy chains were prepared following the procedure of Fleischman, Pain, and Porter (20) , using a Sephadex G100 column equilibrated in 1 M acetic acid (or in some experiments in 3 M guanidine HCl) to separate the reduced and alkylated chains. Although only the mid-third of the first peak was selected for the heavy-chain preparations, only some of these preparations, especially those from X-chain proteins, were essentially pure when tested immunologically.
Aitalytical procedures. Concentrations of the isolated a-CP or their subunits were measured by absorption at 280 mjy using an extinction coefficient E1 cml% = 9.4. This value was established for the protein T. L. by determination of its dry weight and was arbitrarily used for the other a-CP preparations. Total proteinuria in these patients was measured by the biuret reaction after precipitation by trichloracetic acid at a final concentration of 20% at boiling point.
For protein-bound carbohydrate determinations, total hexoses were measured by anthrone reaction according to Mokrasch (21) , D-mannose and D-galactose in 1: 1 molar ratio being used as standard. Fucose was assayed according to the method of Dische and Shettles (22) , using L-fucose as standard. Sialic acid was determined with thiobarbituric acid reagent according to Warren (23) , using N-acetylneuraminic acid as standard. Total hexosamines were determined using the Elson-Morgan reaction as described by Boas (24) ; D-glucosamine converted as free base was used as standard.
To evaluate the role of sialic acid moieties on its electrophoretic heterogeneity, mildy reduced and alkylated T. L. protein was treated with neuraminidase (Behring)3 incubating 1 (27) .
To study the polymeric forms of a-CP and to determine the molecular weight of the monomers, gel filtration experiments were performed on Sephadex G100 and G200 equilibrated with an aqueous solution of 6 M guanidine HCl, 1 mole/liter in acetic acid by upwards elution in columns 80 cm X 2.5 cm I.D. The optical densities of the solvents at 280 mA were less than 0.03. The Sephadex G200 column was calibrated by measuring the Ve/Vo values of the following proteins: human myeloma -yG, human -y-polypeptide chains, hog gastric pepsin, trypsin, human K-polypeptide chains, and horse heart cytochrome c. Th-e Ve/Vo values were plotted vs. log mol wt. .:i mononmer of the a-CP T. L. were performed according to Grey and Mannik (28) . The reduced and alkylated chains (or monomers) were first dialyzed separately against 0.1 M acetic acid. The mixtures were prepared in this solvent in a ratio of H (or monomer) L = 2: 1 on the basis of protein concentration. Subsequently they were dialyzed against distilled water, followed by 0.01 M Tris-HCl buffer, pH 8.0. Each step of dialysis was carried out for 20 hr at 40C using a 100-fold excess of the solvent. The total protein concentration of the mixtures during the dialysis steps was approximately 1.0 mg/ml.
RESULTS
The serum electrophoretic pattern of patients T. L. and D. E. was strikingly abnormal, showing a broad band which extended from a2-to P2-globulins, a decrease in serum albumin possibly due to severe intestinal malabsorption, and a profound hypogammaglobulinemia (Fig. 1) . In both patients the concentration of this fraction was approximately 4 g/100 ml at the time of first study. Immunoelectrophoretic analysis with polyvalent antisera to normal human serum revealed an abnormal precipitin line (Fig. 2 A) extending from the al-globulins to the slow 82-region, crossing at its extremities the serum albumin and YG lines. This abnormal protein reacted with all antisera to yA (Fig. 2 B) .
In the other two patients, no abnormal band was detectable in the serum electrophoretic pattern (Fig. 1) . There was only an increase of the a2-globulins, contrasting with a decrease of all other protein fractions, and in most samples a moderate hypogammaglobulinemia. The wA abnormality could have escaped routine immunoelectrophoretic analysis with antiserum to whole normal serum, especially in case S. I. (Fig. 3) . However, immunoelectrophoretic analysis with antisera to -yA showed an abnormally fast precipitin line (Fig. 3 B) , which was hidden amongst the a2-globulin lines and barely visible when using the polyvalent antisera (Fig. 3 A) . acids. The sera, used as carriers, and the antisera are the same that appear at the left. Note that the only labeled line is that corresponding to 'yA-and a-chain disease protein (a-CP) and that there is no reaction with the antisera to light chains.
X-light chains were present in 'vG and yM in a roughly normal ratio. Immunochemical quantitation of the pathological yA-protein by radial diffusion could not give reliable figures because of its tendency to polymerize (see below) and because of the lack of valid standard for a calibration curve.
Antigenic analysis of the serum protein. In each of the four patients, the anomalous yA component was not seen in immunoelectrophoretic patterns developed with several antisera specific for K-or X-light chains (Fig. 2 C and D) . Moreover, the isolated pathological protein did not combine with anti-K or anti-x antibodies and did not inhibit their precipitin reaction with Bence Jones proteins. ImmunoelectroAntfi-oN FIGURE 3 Immunoelectrophoretic analysis and subsequent radioautography of a cell extract from an intestinal biopsy culture of patient S. I. in presence of '4C-labeled amino acids.
The carriers were 1 Al of serum of the patient S. I. (top wells) and 1 Al of normal human serum (lower wells). Note: (a) that the fast a-CP precipitin line in serum S. I. is easily detected with antiserum to -yA (anti-a) but escapes to analysis with antiserum to whole normal serum (anti-N'S) because it is hidden among the a2-globulin lines; (b) that the only labeled line is that corresponding to -yA and to a-CP; (c) that the slight spur of normal -yA over a-CP in serum S. I. (middle pattern with anti-yA) is not seen on the radioautograph. In this particular experiment, the anodic end of the a-CP precipitin line is not labeled. 5 C) ; (b) with some antisera, yA-myeloma proteins with K-chains, but not those with X-chains, spurred over the a-CP, although the precipitin lines of the myeloma proteins of both light-chain types fused completely ( Fig. 5 A) ; (c) inversely, other antisera showed a spur of -vA-myeloma proteins of type L, and not of those of type K over the pathological proteins ( Fig.  5 B) ; (d) when using two of our antisera made against K yAl-myeloma protein, a-CP were found to be deficient when compared with all tested -yA-myeloma proteins of type K as well as of type L (Fig. 5 D) . However, even this latter pattern was due to antibodies related to conformational specificity and light-heavy chain interaction since the same antisera showed complete identity between FIGURE 4 Immunoelectrophoresis of sera S. I., A. I., and D. E. using a specific antiserum to yA which contains antibodies reacting with the light-heavy chain combination. These patterns show in all sera a precipitin line corresponding to normal yA. This line spurs over the a-CP line of sera S. I. and A. I. at their cathodic extremity, whereas it is inside the a-CP line for serum D. E.
the a-CP and the purified heavy chains from the myeloma proteins. Moreover, after absorption of these antisera with the purified a-CP, no more reaction was detectable with the purified myeloma heavy chains, whereas these absorbed antisera gave a precipitin reaction with the yA-myeloma proteins. The pathological proteins of all four patients were shown to belong to the al-subclass (Fig. 6) . When antisera demonstrating the antigenic deficiency of yA2-myeloma proteins were used, the a-CP gave a reaction of identity with yAl-myeloma proteins and spurred over yA2-nmyeloma proteins (Fig. 6 A) . None of the purified a-CP (up to a concentration of 10 mg/ml) precipitated with an antiserum specific for the yA2-subclass (Fig.  6 B) . Immunoelectrophoretic experiments showed that, in contrast, the normal yA-globulin of patient S. I. containe(l a small proportion of 7A2-molecules. gradient ultracentrifugation showed that the a-CP was widely distributed along the gradient and was present in fractions heavier than aG as well as in those containing albumin. When the block electrophoresis fraction containing the aCP was subjected to Sephadex G200 gel filtration, a large fraction of the pathological protein was eluted in the first asymmetrical peak (shown on Fig. 8 B) , together with yM-and a2M-contaminants. Since the small amount of normal 'yA present in the serum was eluted in the last third of this 1st peak (fraction 3 of the figure), only the first two-thirds of the peak were pooled for further purification. Purification was achieved for all the a-CP except protein S. I. Ultracentrifugal analysis of this purified material showed considerable mass heterogeneity with several peaks ranging from 8S to 12S. When submitted to urea-acid-starch-gel electro-401 OD280~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~.
. . . When the mildly reduced and alkylated purified a-CP from patients T. L., D. E., and A. I. were submitted to urea-acid-starch-gel electrophoresis, the characteristic band of the light polypeptide chains was always lacking and the "heavy-chain band" was diffuse (Fig. 9) . Extensively reduced and alkylated T. L. protein gave the same electrophoretic pattern in urea-acid starch gel.
Gel filtration experiments with the reduced and alkylated a-CP on a calibrated Sephadex G200 column in 6 M guanidine HCl, 1 M acetic acid allowed a rough estimate of the molecular weights of the monomeric units of the purified proteins. The values obtained were approximately 36,000, 38,000, and 38,000 for T. L., A. I., and D. E., respectively.
Attempts to combine the monomeric units of T. L.-and D. E.-a-CP with purified light chains of YAmyeloma proteins were unsuccessful, whereas the control experiments performed with the same light chains and alpha chains of heterologous myeloma proteins yielded recombined molecules.
The carbohydrate content of the three purified a-CP, as compared to a-chains of a^yA1-myeloma is indicated in Table II . The strikingly high concentration of sialic acid and hexosamines in proteins T. L. and D. E. (confirmed when studying the urinary protein) was not found for protein A. I.
T. L. protein monomer was digested with neuraminidase and then submitted to agar-gel electrophoresis and to starch-gel electrophoresis in borate buffer, pH 8.6. Although the anodic mobility was considerably reduced as compared with that of the untreated material, there was no significant reduction in the degree of charge heterogeneity after neuraminidase treatment which had removed all sialic acid moieties.
Study of the urine, jejunal fluid, and saliva protein. Since a-CP are poorly precipitable in sulfosalycilic acid and 10% trichloracetic acid, probably owing to their high carbohydrate content, quantitative estimates of the proteinuria by these routine methods were inaccurate. The thermosolubility test for Bence Jones proteins was always negative. The amount of protein excreted in the urine was generally low and varied from day-to-day. It ranged between 0.05 and 1 mg/ml for patient T. L. an(l between 0.15 and 0.50 mg/ml for patient D. E., except for one sample which contained 1.8 mg/ml. In patients S. I. and A. I., total proteinuria never exceeded 0.2 mg/ml. In all four cases, the a-CP was found in concentrated urines. For cases T. L. and D. E., the electrophoretic pattern showed a broad abnormal band (Fig.  10 A) Fig.  10 B, whereas the a-CP in serum did not react with antisera to secretory piece. Jejunal fluid was studied for all patients except T. L. The a-C.P. was always detected and immunoelectrophoretic analysis showed that, in all the studied samples. this protein was the main component reacting with antisera to whole normal human serum. The precipitin arc revealed by antisera specific for wA was similar to that of the serum pattern. Here again, the pathological protein was shown to lack light chains and to be associated with the secretory piece.
The abnormal protein was never found in parotid saliva in the several specimens obtained from patients D. E., S. I., and A. I. For patient T. L., the a-CP was shown to be present in significant amounts (4), but only total saliva had been studied. In this case, however, studies of total saliva are inconclusive as illustrated by the fact that patient D. E. exhibited a-CP in total saliva although not detected in its parotid saliva. This may simply reflect an inflammatory state of the buccal mucosa. Normal secretory wA was shown to be present in decreased amounts in all parotid saliva samples except for the initial sample of one of the patients.
In the course of these studies, we found that the antibodies reacting specifically with the a-light-chain combination were unable to precipitate with normal secretory wA in saliva, urine, or intestinal fluid. However secretory 'YA does inhibit the precipitin reaction of these antibodies with serum yA. This finding suggests that the conformational specificity of the Fab region is modified when secretory piece is bound to the yAmolecule (29) . Cellular synthesis studies. The results of the immunofluorescence study of small intestine biopsies were essentially similar for all four patients (Fig. 11) . When the sections were treated with conjugated antisera to yA, a diffuse or patchy fluorescence caused by extracellular material was seen in many specimens (Fig. 11 A) . The cytoplasm of the proliferating lymphoid and plasma cells forming a dense infiltrate in the lamina propria was either faintly fluorescent (Fig. 11 B) or negative (Fig.  11 C) . On a surgical biopsy specimen of one of the patients, it was clear that the fluorescent cells were not evenly distributed, but localized in some zones. Very occasional brightly fluorescent cells stained by anti-yA antiserum were seen, in contrast to the poorly stained sheets of proliferating cells. We vainly attempted to increase the brilliance of this cytoplasmic fluorescence by using different technical variations including conjugated anti-T. L. protein antiserum and the indirect method with unconjugated antisera to yA. Results were constantly negative both for the extracellular material and for the proliferating cells with several anti-light-chain antisera, apart from an exceptional bright cell clearly seen on the dark background and presumably synthesizing a normal Ig molecule. YG-producing cells were practically absent, while yM cells were somewhat more frequent, sometimes in small clumps in the vicinity of eosinophils.
Radioimmunoelectrophoretic analysis of the proteins synthesized in vitro by the same small intestine biopsy specimens demonstrated the production of the a-CP in all instances (Fig. 2 and 3) . Multiple biopsy specimens for each of the four patients were studied by this technique and the yA precipitin line was always strongly labeled when normal serum was used as carrier. When the serum of the corresponding patient was used as carrier, the a-CP line was also strongly labeled. In several instances, the use of a carrier serum was unnecessary because the amount of labeled a-CP present in the cellular extract was sufficient to give a precipitin line which was shown to be antigenically deficient when compared with normal yA. For most specimens. -yA was the only labeled immunoglobulin line when normal serum was used as carrier. Occasionally aG and/or -yM lines were faintly labeled. The a-CP synthesized in vitro never reacted with antisera to K-or X-light chains in contrast to normal secretory yA in control experiments performed with normal intestine. No free labeled light chains could be demonstrated in the cell extracts, even if light chains were used as carriers. A rectal biopsy of patient A. I. showed involvement by the proliferative process and the corresponding specimens also synthesized the a-CP in vitro. 6 Mesenteric lymph nodes removed at surgery from patients A. I. and S. I. were studied by the same technique. In both cases, the synthesis of a significant amount of a-CP was demonstrated and the use of a carrier serum for the radioimmunoelectrophoretic analysis was unnecessary. When normal serum was used as carrier, yA 6 In the course of these experiments, we found that all the small intestinal or rectal specimens from two patients synthesized in uncontaminated cultures a component with almobility. Although strongly labeled on the radioautographs, the corresponding line was not detectable on the stained plates. This component was seen whether or not human serum was used as carrier. It was revealed by most but not all rabbit antisera, by pooled normal rabbit serum, pooled normal human serum, purified normal SyG, but not by human agammaglobulinemic sera. The hypothesis of a blood group substance reacting with rabbit and human -yG was considered but has not been substantiated by preliminary experiments. Fig. 12 . With the antisera to -YA, approximately half of the cells were positive. The stained cells were either plasma cells or medium to large lymphoid cells. Although the result was more clear-cut than with intestine sections, the cytoplasmic fluorescence was not very intense and one could notice cells with varying degrees of brightness (Fig. 12A) . With antisera to K-and X-light chains, the cells were negative, apart from one exceptional bright cell presumably synthesizing a normal complete immunoglobulin (Fig.  12 B) .
Bone marrow smears showed a normal immunofluorescence pattern for all patients except T. L., and no in vitro synthesis of a-CP was detected by raidoimmunoelectrophoretic analysis. The immunofluorescence study of the bone marrow of patient T. L. demonstrated a moderate involvement by the neoplastic process. On three occasions, 4-6% of the nucleated cells (half plasma cells and half medium to large lymphoid cells) were positive with the antisera to 'vA, whereas the reactions were consistently negative with anti-K and anti-X antisera, except for an extremely small number of cells corresponding to 7G-and 7M-producing cells. In vitro synthesis experiments confirmed the production of a small amount of T. L. a-CP.
DISCUSSION
The present studies show that the anomalous protein of alpha chain disease is in many respects similar to that of av-heavy-chain disease (2, (30) (31) (32) (33) . The lack of light chains was demonstrated by several immunological and chemical methods. It should be emphasized that the absence of precipitation with antisera to light chains is not a sufficient criterion since such a failure to precipitate has been encountered in this and other (34) laboratories with several -vA-myeloma proteins, mainly with X-chains. Rabbit antisera containing antibodies which give precipitin reactions only when light and a-heavy chains are combined were found to be especially useful for detection of the pathological protein without purification. In addition to antisera with antibodies specific for the a-r or a-X combination (35), we found during this study that some antisera contained antibodies reacting with the combination of a-chains with any K-or X-light chains. These findings confirm the importance of the light-heavy chain interaction in establishing the antigenic structure of the immunoglobulin molecules (36, 
37).
The molecular weight estimations in calibrated Sephadex column indicate that the three studied abnormal proteins represent only a portion (roughly two-thirds) of al-chain. These data have been recently confirmed by precise molecular weight determinations by the meniscus depletion method of Yphantis in guanidine.7 That a-CP are related to the Fc-fragment of 'vA is indicated by antigenic analysis and by the presence of a carboxyterminus similar to that of myeloma a-chains. 8 The lack of at least a portion of the Fd-piece could not be convincingly demonstrated by immunological techniques with the available antisera because of the poor immunogenicity of the Fd piece. However, the inability of the anomalous proteins to combine with light chains suggested that Fd piece or a portion thereof is missing. Further structural studies are required in order to determine precisely the length and location of the segment of Fd piece which is missing in these a-CP. The study of the NH2-terminal region is of the utmost importance since diverging data have been found for 'y-heavy-chain 7Dorrington, K. J., and M. Seligmann. In preparation. 8 Mihaesco, Edith. Unpublished data. disease proteins. Prahl (38) proteins recalls the original observation for the '-heavychain disease protein CR (9) , and remains to be explained. The striking electrophoretic heterogeneity of the a-CP is presumably not due to the sialic acid moieties, as demonstrated by Grey for one of the 'v-chain disease proteins (39) . This electrophoretic heterogeneity may be partly related to the very high tendency of a-CP to polymerize. The polymers held together by noncovalent bonds in addition to disulfide bonds were shown, to occur in vivo. The discrepancy between the ultracentrifugal and gel filtration data remains to be explained. The tendency towards polymerization may explain the low output of the anomalous protein in urine.
When studied with antisera to 'A, the antigenic properties of the anomalous protein found in urine and, in significant amount, in jejunal fluid of all patients were similar to that of the serum protein. The finding that the a-CP in urine and jejunal fluid of two patients was associated with secretory piece suggests that piece is bound to the Fc-region of the secretory 'A-molecules.
All four proteins belonged to the al-subclass which constitutes about 85% of the normal 'vA-molecules (13) . Although these four a-CP are immunologically indistinguishable with the available antisera, structural differences between them may be detected by future chemical studies. That these proteins were "monoclonal" in nature, despite their electrophoretic heterogeneity, could be proven only by the negative reactions with the antiserum specific for the 'vA2-subclass. This monoclonal character is in good agreement with the neoplastic nature of the cellular infiltration in the gut and the involved lymph nodes (4, (7) (8) (9) .
The cellular studies clearly show that the a-CP is synthesized by the proliferating cells present in the small intestine (all patients), mesenteric nodes (2/2 patients), bone marrow (1/4), and rectum (1/2). Electron microscopic studies for patients D. E. and A. I. substantiated that most of these cells were plasma cells (8, 9) . In addition, the present studies have confirmed in all four patients that there is no detectable light-chain synthesis at the intracellular level (3). A similar observation has been recently made in a patient with 'v-heavy-chaini disease (33) . However, in this latter study the radioimmunoelectrophoretic experiments were performed with the supernatant fluid of the cultures, whereas in the present work the cell extracts were used and were shown to be devoid of free labeled light chains. The data indicate that this is not an absence of light-heavy chain assembly and suggest that the genes coding for light chains (and possibly part of the heavy chain) are not expressed in these tumor cells. If confirmed by studies of nascent immunoglobulin subunits on polysomes, these findings would imply that the incomplete heavy chains are released from the polysomes and secreted despite the absence of light chains. This is in contrast to the current hypothesis on the mechanisms of intracellular assembly (40, 41) and secretion (42) of immunoglobulin molecules. While the findings in these patients do not invalidate these hypotheses, they suggest that at least in certain abnormal situations light chains are not required to ensure release of heavy chains and transport across the rough endoplasmic reticulum. The faint positivity of the proliferating cells found in all four patients by immunofluorescent study with antisera to yA remains to be explained. A possible explanation for this unexpected finding is that the abnormal alpha chain might be rapidly secreted from the cells, so that the net intracellular pool of this protein would as a result, be low. The low periodic acid-Schiff (PAS) positivity of the majority of the tumor cells (4) contrasting to the high carbohydrate content of a-CP is in agreement with this hypothesis. In view of recent reports on the possible role of carbohydrate in the Ig secretion (43) , the postulated fast release of a-CP from the cells could be related to its very high carbohydrate content. In addition, the sugar moieties could possibly protect the Fc-region of a nascent intact a-chain from an intracellular proteolytic process, thus leading to the presence of a-CP. Further biosynthesis studies are required to clarify these points.
That alpha chain disease primarily involves the intestinal tract is not an unexpected finding in view of the importance of the digestive lymphoid tissue in the YAsynthesis (44) . However, it is in contrast to the rarity of gastrointestinal involvement in disseminated myeloma (45) and, in our experience, in 'yA-myelomas. The clinicopathological features (4, (7) (8) (9) were strikingly similar in the four patients herein studied and similar to those in the so-called "Mediterranean" type of abdominal lymphoma described by Israeli authors (5, 6, 46) who emphasized that, in their experience, this type of lymphoma occurred only in young Arabs and non-Ashkenazi Jews. Two of our patients with a-chain disease were Kabyles from Algeria, one a Syrian Arab, and the fourth a Eurasian with a French father and a Cambodian mother. A fifth patient with a-chain disease, also found in a Paris hospital and very recently diagnosed in this laboratory, is also a young Algerian. This striking predilection for some populations may be a result of the action of environmental factors, such as intestinal microorganislis, or of a genetic predisposition similar to that found in Waldenstrdm macroglobulinemia (47) or of both. A study of immunoglobulins of the relatives of our patients with a-chain disease has been undertaken and the first results are uninformative. Two other important questions remain: (a) Will a-CP abnormality be found in clinical syndromes other than lymphoma of the digestive tract? (b) Do most or only few cases of "Mediterranean" type of abdominal lymphoma represent a-chain disease? Unfortunately, none of the previously described cases included an immunoglobulin analysis. However, a case recently reported by Jinich, Rojas, Webb, and Kelsey (48) in an Irakian Jew living in Mexico City could have been an unrecognized a-chain disease since "hypergammaglobulinemia" of 3.6 g/100 ml was recorded. Through the courtesy of Doctors Bracha Ramot (TelAviv), Zlotnick (Jerusalem), and Hobbs (London), we have been able to identify a-CP in the serum of four additional patients with this type of abdominal lymphoma. Thus, it seems highly probable that, although previously unrecognized, a-chain disease is less infrequent than -v-heavy-chain disease.9
